GE
Genmab A/S
GE9.F · FSX
301.30 € +1.21% (+3.60 €)
1M +4.76%
Market Cap $21.0B
P/E Ratio 26.89x
Div. Yield -
ROE 13.48%
Bulios Fair Price
416.87 €
38.4% upside
Trenutna cena
301.3 €
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GE9.F trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
43 /100
Fair P/E 26.89x
P/B 3.54x
EV/EBITDA 18.12x
Growth
0 /100
Declining EPS growth 42.26%
Book val. growth 40.24%
Rev. growth 35.73%
Profitability
100 /100
Strong Gross margin 93.03%
FCF margin 21.22%
Net margin 19.07%
Quality
53 /100
Average ROIC 9.86%
Asset turnover 0.33x
ROE 13.48%
Debt
60 /100
Moderate Debt/Equity 0.89x
Net debt/EBITDA 2.75x
Current ratio 2.46x
Stability
40 /100
Moderate Beta 0.69x
Profitable years 6
Rev. volatility 60.78%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GE9.F
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jan van de Winkel
Employees
3,029
Headquarters
Copenhagen
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report